Kerrisdale Advisers’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-100,000
| Closed | -$429K | – | 42 |
|
|
2021
Q3 | $429K | Buy |
+100,000
| New | +$429K | 0.05% | 55 |
|
|
2021
Q2 | – | Sell |
-208,150
| Closed | -$693K | – | 55 |
|
|
2021
Q1 | $693K | Buy |
+208,150
| New | +$693K | 0.05% | 52 |
|
|
2013
Q4 | – | Sell |
-90,057
| Closed | -$626K | – | 55 |
|
|
2013
Q3 | $626K | Buy |
90,057
+54,497
| +153% | +$379K | 0.29% | 47 |
|
|
2013
Q2 | $167K | Buy |
+35,560
| New | +$167K | 0.08% | 57 |
|